BetterLife Pharma (BETRF) Research & Development (2011 - 2026)
BetterLife Pharma (BETRF) reported Research & Development of $47,780 for fiscal Q2 2027 (quarter ended Jul 31, 2026), compared with $1,148 a year earlier and up 204.6% from the prior quarter.
Powered by 
Analysis
BetterLife Pharma (BETRF) Research & Development (2011 - 2026) Analysis & Trends
Over the twelve months ended Jul 31, 2026, BetterLife Pharma's Research & Development came in at $74,187, up 92.4% year-over-year; for FY2026 (ended Jan 31, 2026), it came in at $61,535, down 80.0% from FY2025.
- Research & Development has declined for four consecutive fiscal years, with a five-year compound annual growth rate of -22.0% (FY2021 to FY2026).
- By fiscal year, Research & Development came in at $308,121 in FY2025 (-27.2%), $423,263 in FY2024 (-79.3%), $2.05 million in FY2023 (-52.7%) and $4.33 million in FY2022.
- The fiscal Q2 2027 figure ranks as the highest quarterly Research & Development since fiscal Q2 2025.
- Year over year, Research & Development gained in 1 of the last five quarters, with an average decline of 60.5%.
- The high point for year-over-year Research & Development in five years was fiscal Q3 2024 (growth of 405.4%); the low point was fiscal Q2 2026 (a decline of 99.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,133.99 Bn | 1,102.58 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 615.70 Bn | 534.23 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 501.05 Bn | 474.16 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 367.41 Bn | 321.79 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.20 Bn | 234.88 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 235.55 Bn | 190.95 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 190.64 Bn | 164.84 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 169.29 Bn | 115.93 Bn | 10.94 Bn | 2.81 Bn |
| 10 | BetterLife Pharma | 26.10 Mn | 25.36 Mn | - | 47,779.94 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 47,779.94 |
| Apr 30, 2026 | 15,685.84 |
| Jul 31, 2025 | 1,148.45 |
| Apr 30, 2025 | 9,573.27 |
| Jan 31, 2025 | 22,431.77 |
| Oct 31, 2024 | 5,400.63 |
| Jul 31, 2024 | 197,393.83 |
| Apr 30, 2024 | 84,690.19 |
| Jan 31, 2024 | 137,587.46 |
| Oct 31, 2023 | 98,458.38 |
| Jul 31, 2023 | 138,452.11 |
| Apr 30, 2023 | 49,253.93 |
| Jan 31, 2023 | 318,262.83 |
| Oct 31, 2022 | 19,479.66 |
| Jul 31, 2022 | 238,557.76 |
| Apr 30, 2022 | 1.51 Mn |
| Jan 31, 2022 | 524,118.03 |
| Oct 31, 2021 | 949,250.78 |
| Jul 31, 2021 | 1.82 Mn |
| Apr 30, 2021 | 1.05 Mn |
API Access
BetterLife Pharma Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=BETRF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "BETRF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=BETRF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();